Did anyone really read this PR before they bought the stock. It was $11-$12 in pre-market last I saw. It's going to do a Phase I trial in "non-human primates". Are you kidding me?

Not referring to anyone here, BTW. I was watching it pre-market. Didn't check again until the end of the day.